#N501Y

The Conversation

ConversationUK

I am a genomics researcher and I investigated mutations in more than 50,000 coronavirus genomes so far this year.This new variant has a number of features that could raise concern

Florian Krammer

florian_krammer

1) So, this morning I promised a little tweetorial about variants and here we go. This will be from a vaccine/antibody point of view only, I won't comment on how

Dr Harsh Vardhan

drharshvardhan

Disgraceful for anyone to politicise such a critical issue. Sh @ShashiTharoor, Sh @yadavakhilesh & Sh @Jairam_Ramesh don't try to discredit well laid out science-backed protocols followed for approving #COVID19vaccines Wake

Bill Hanage

BillHanage

But I will note that mutations happen all the time. The more infections, the more opportunities to explore the the space of possible mutations. Basically you wouldn't have expected this

Simply Biochemistry

SimplyBiochem

1) THREAD - Why the new SARS-CoV-2 UK variant is NOT a new strain.Unfortunately the way this recent development has been reported has upset a lot in the scientific community.

Carl T. Bergstrom

CT_Bergstrom

After many months with little to suggest that SARS-CoV-2 was evolving to transmit more readily or evade immune responses, we are now concerning variants such as B.1.1.7 emerge and spread,

aHEMagain Actual

aHEMandias

Correlation isn't causation. Increased detection of #COVID19 Variant Under Investigation (VUI-202012/01) is occurring at same time as a general surge in coronavirus infections in UK. IMO it's premature to claim

Eric Billy 🇫🇷🇪🇺

EricBillyFR

Mode info COVID:les vaccins protègent-ils des variants?Plusieurs travaux en cours de publication répondent a la question.Version courte: oui.Est-ce pour cela qu'on peut laisser courir le nombre de cas+? Non car

Rebecca Morelle

BBCMorelle

Very good news on #Novavax vaccine in UK trial - reduced efficacy in South Africa (50-60%) not so great news (1) https://www.bbc.co.uk/news/uk-55850352 Interesting as this vaccine trial was able to

Jeffrey Barrett

jcbarret

One of the key questions about the new variant (B.1.1.7) is whether there is conclusive evidence that it is more transmissible. I don't think we are absolutely certain yet, but

Trevor Bedford

trvrb

After ~10 months of relative quiescence we've started to see some striking evolution of SARS-CoV-2 with a repeated evolutionary pattern in the SARS-CoV-2 variants of concern emerging from the UK,

Dr Emma Hodcroft

firefoxx66

There are many, many #SARSCoV2 #COVID19 variants out there! A few have caught the attention of scientists in Europe - we're trying to monitor them!I'll be maintaining updated information here:https://github.com/emmahodcroft/cluster_

Eric Feigl-Ding

DrEricDing

BREAKING—A new #SARSCoV2 variant (aka B.1.1.248) identified by Japan in pax from Brazil . This new one has both the more infectious N501Y mutation (not affect vaccine), as well

Monica Gandhi MD, MPH

MonicaGandhi9

Pfizer study shows vaccine should work against this B.1.1.7 UK and South Africa variant of SARS-CoV-2. mRNA sequence in Pfizer vaccine likely propietary but Pfizer took a virus with the

Dr. Ali Nouri

AliNouriPhD

1/The UK #SARSCoV2 variant reported to be 70% more transmissible harbors a set of mutations in the Spike protein––the part of the virus that touches the human ACE2 receptor and

Eric Feigl-Ding

DrEricDing

Mutation “feat never seen before”...UPDATE on UK strain of #SARSCoV2 & how it evolved so fast:Variant B.1.1.7 (aka VUI-202012-01) has 23 mutations—but acquired suddenly 17 mutations “all at once”—which

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.